Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Christopher C. Marino"'
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
Aromatase inhibitors (AIs) are a key component in the chemoprevention and treatment of hormone receptor-positive (HR+) breast cancer. While the addition of AI therapy has improved cancer-related outcomes in the management of HR+ breast cancer, AIs ar
Externí odkaz:
https://doaj.org/article/91f8fd0165334196a90a3727462e844c
Autor:
Jana L Jacobs, Ghady Haidar, Asma Naqvi, Kevin D McCormick, Michele Sobolewski, Benjamin R Treat, Amy L Heaps, Jordan Simpson, Kailey Hughes Kramer, Erin McCreary, J Ryan Bariola, Cynthia Klamar-Blain, Bernard J C Macatangay, Dimiter Dimitrov, Wei Li, Christopher C Marino, Anastasios Raptis, Rahil Sethi, Uma Chandran, Simon Barratt-Boyes, Urvi M Parikh, John W Mellors
Publikováno v:
Open Forum Infectious Diseases. 10
Prolonged coronavirus disease 2019 may generate new viral variants. We report an immunocompromised patient treated with monoclonal antibodies who experienced rebound of viral RNA and emergence of an antibody-resistant (>1000-fold) variant containing
Autor:
Ghady Haidar, Jana L Jacobs, Kailey Hughes Kramer, Asma Naqvi, Amy Heaps, Urvi Parikh, Kevin D McCormick, Michele D Sobolewski, Mounzer Agha, Tatiana Bogdanovich, Vasilii Bushunow, Rafic Farah, Matthew Hensley, Yen-Michael S Hsu, Bruce Johnson, Cynthia Klamar-Blain, Jennifer Kozar, Elizabeth Lendermon, Bernard J C Macatangay, Christopher C Marino, Anastasios Raptis, Erin Salese, Fernanda P Silveira, Ann M Leen, William L Marshall, Michael Miller, Badrish Patel, Ercem Atillasoy, John W Mellors
Publikováno v:
Clinical Infectious Diseases.
We administered severe acute respiratory syndrome coronavirus-2 viral-specific T cells (VSTs) under emergency investigational new drug applications to 6 immunocompromised patients with persistent coronavirus disease 2019 (COVID-19) and characterized
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
Frontiers in Endocrinology
Frontiers in Endocrinology
Aromatase inhibitors (AIs) are a key component in the chemoprevention and treatment of hormone receptor-positive (HR+) breast cancer. While the addition of AI therapy has improved cancer-related outcomes in the management of HR+ breast cancer, AIs ar
Autor:
Sukanta Jash, Garrett Heinrich, Christopher C. Marino, Simona S. Ghanem, Hilda E. Ghadieh, Cara Gatto-Weis, Kevin Y. Lee, Julie C. Hanna, Harrison T. Muturi, Sonia M. Najjar, Vishwajeet Puri, Saja S. Khuder, Lucia Russo
Publikováno v:
Hepatology Communications
Exenatide, a glucagon‐like peptide‐1 receptor agonist, induces insulin secretion. Its role in insulin clearance has not been adequately examined. Carcinoembryonic antigen‐related cell adhesion molecule 1 (CEACAM1) promotes hepatic insulin clear
A small-group functional balance intervention for individuals with Alzheimer disease: a pilot study.
Autor:
Ries JD; Department of Physical Therapy, Marymount University, Arlington, Virginia, USA. Julie.ries@marymount.edu, Drake JM, Marino C
Publikováno v:
Journal of neurologic physical therapy : JNPT [J Neurol Phys Ther] 2010 Mar; Vol. 34 (1), pp. 3-10.
Autor:
Levin B, Barthel JS, Burt RW, David DS, Ford JM, Giardiello FM, Gruber SB, Halverson AL, Hamilton S, Kohlmann W, Ludwig KA, Lynch PM, Marino C, Martin EW Jr, Mayer RJ, Pasche B, Pirruccello SJ, Rajput A, Rao MS, Shike M, Steinbach G, Terdiman JP, Weinberg D, Winawer SJ
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2006 Apr; Vol. 4 (4), pp. 384-420.